Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Structural centrosome aberrations sensitize polarized epithelia to basal cell extrusion.

Ganier O, Schnerch D, Nigg EA.

Open Biol. 2018 Jun;8(6). pii: 180044. doi: 10.1098/rsob.180044.

2.

Impact of Centrosome Aberrations on Chromosome Segregation and Tissue Architecture in Cancer.

Nigg EA, Schnerch D, Ganier O.

Cold Spring Harb Symp Quant Biol. 2017;82:137-144. doi: 10.1101/sqb.2017.82.034421. Epub 2018 Apr 2.

PMID:
29610243
3.

Structural centrosome aberrations promote non-cell-autonomous invasiveness.

Ganier O, Schnerch D, Oertle P, Lim RY, Plodinec M, Nigg EA.

EMBO J. 2018 May 2;37(9). pii: e98576. doi: 10.15252/embj.201798576. Epub 2018 Mar 22.

4.

Proteasome inhibition enhances the efficacy of volasertib-induced mitotic arrest in AML in vitro and prolongs survival in vivo.

Schnerch D, Schüler J, Follo M, Felthaus J, Wider D, Klingner K, Greil C, Duyster J, Engelhardt M, Wäsch R.

Oncotarget. 2017 Mar 28;8(13):21153-21166. doi: 10.18632/oncotarget.15503.

5.

Suppression of APC/CCdh1 has subtype specific biological effects in acute myeloid leukemia.

Ewerth D, Schmidts A, Hein M, Schnerch D, Kvainickas A, Greil C, Duyster J, Engelhardt M, Wäsch R.

Oncotarget. 2016 Jul 26;7(30):48220-48230. doi: 10.18632/oncotarget.10196.

6.

The role of APC/C(Cdh1) in replication stress and origin of genomic instability.

Greil C, Krohs J, Schnerch D, Follo M, Felthaus J, Engelhardt M, Wäsch R.

Oncogene. 2016 Jun 9;35(23):3062-70. doi: 10.1038/onc.2015.367. Epub 2015 Oct 12.

PMID:
26455319
7.
8.

Metadherin exon 11 skipping variant enhances metastatic spread of ovarian cancer.

Haug S, Schnerch D, Halbach S, Mastroianni J, Dumit VI, Follo M, Hasenburg A, Köhler M, Dierbach H, Herzog S, Proske A, Werner M, Dengjel J, Brummer T, Laßmann S, Wäsch R, Zeiser R.

Int J Cancer. 2015 May 15;136(10):2328-40. doi: 10.1002/ijc.29289. Epub 2014 Nov 8.

9.

Up-regulation of RUNX2 in acute myeloid leukemia in a patient with an inherent RUNX2 haploinsufficiency and cleidocranial dysplasia.

Schnerch D, Lausch E, Becker H, Felthaus J, Pfeifer D, Mundlos S, Engelhardt M, Schwabe M, Wäsch R.

Leuk Lymphoma. 2014 Aug;55(8):1930-2. doi: 10.3109/10428194.2013.855310. Epub 2014 Feb 24. No abstract available.

PMID:
24138303
10.

The 3' untranslated region of the cyclin B mRNA is not sufficient to enhance the synthesis of cyclin B during a mitotic block in human cells.

Schnerch D, Follo M, Felthaus J, Engelhardt M, Wäsch R.

PLoS One. 2013 Sep 13;8(9):e74379. doi: 10.1371/journal.pone.0074379. eCollection 2013.

11.

BubR1 is frequently repressed in acute myeloid leukemia and its re-expression sensitizes cells to antimitotic therapy.

Schnerch D, Schmidts A, Follo M, Udi J, Felthaus J, Pfeifer D, Engelhardt M, Wäsch R.

Haematologica. 2013 Dec;98(12):1886-95. doi: 10.3324/haematol.2013.087452. Epub 2013 Jun 28.

12.

Potent in vitro and in vivo activity of sorafenib in multiple myeloma: induction of cell death, CD138-downregulation and inhibition of migration through actin depolymerization.

Udi J, Schüler J, Wider D, Ihorst G, Catusse J, Waldschmidt J, Schnerch D, Follo M, Wäsch R, Engelhardt M.

Br J Haematol. 2013 Apr;161(1):104-16. doi: 10.1111/bjh.12226. Epub 2013 Feb 6.

PMID:
23384035
13.

Studying proteolysis of cyclin B at the single cell level in whole cell populations.

Schnerch D, Follo M, Felthaus J, Engelhardt M, Wäsch R.

J Vis Exp. 2012 Sep 17;(67):e4239. doi: 10.3791/4239.

14.

Cell cycle control in acute myeloid leukemia.

Schnerch D, Yalcintepe J, Schmidts A, Becker H, Follo M, Engelhardt M, Wäsch R.

Am J Cancer Res. 2012;2(5):508-28. Epub 2012 Aug 20.

15.

Monitoring APC/C activity in the presence of chromosomal misalignment in unperturbed cell populations.

Schnerch D, Follo M, Krohs J, Felthaus J, Engelhardt M, Wäsch R.

Cell Cycle. 2012 Jan 15;11(2):310-21. doi: 10.4161/cc.11.2.18737. Epub 2012 Jan 15.

PMID:
22214763
16.

Management of multiple myeloma in pregnancy: strategies for a rare challenge.

Kasenda B, Rückert A, Farthmann J, Schilling G, Schnerch D, Prömpeler H, Wäsch R, Engelhardt M.

Clin Lymphoma Myeloma Leuk. 2011 Apr;11(2):190-7. doi: 10.1016/j.clml.2011.03.009. Epub 2011 Apr 9. Review.

PMID:
21575923
17.

BI_2536--targeting the mitotic kinase Polo-like kinase 1 (Plk1).

Wäsch R, Hasskarl J, Schnerch D, Lübbert M.

Recent Results Cancer Res. 2010;184:215-8. doi: 10.1007/978-3-642-01222-8_15. Review.

PMID:
20072841
18.

The ubiquitin ligase APC(Cdh1) is required to maintain genome integrity in primary human cells.

Engelbert D, Schnerch D, Baumgarten A, Wäsch R.

Oncogene. 2008 Feb 7;27(7):907-17. Epub 2007 Aug 13.

PMID:
17700535
19.

[Origin and role of aneuploidy in cancer].

Schnerch D, Hasskarl J, Engelhardt M, Wäsch R.

Dtsch Med Wochenschr. 2006 Aug 4;131(31-32):1747-53. German.

PMID:
16868879

Supplemental Content

Loading ...
Support Center